Michael Dicay

2.4k total citations
26 papers, 1.9k citations indexed

About

Michael Dicay is a scholar working on Molecular Biology, Pharmacology and Surgery. According to data from OpenAlex, Michael Dicay has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Pharmacology and 6 papers in Surgery. Recurrent topics in Michael Dicay's work include Inflammatory mediators and NSAID effects (8 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Gastrointestinal motility and disorders (5 papers). Michael Dicay is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Gastrointestinal motility and disorders (5 papers). Michael Dicay collaborates with scholars based in Canada, United States and Italy. Michael Dicay's co-authors include John L. Wallace, Webb McKnight, Gary R. Martin, Wallace K. MacNaughton, Linda Vong, Li Ma, Morley D. Hollenberg, André Klein, Rafael Perini and Piero Del Soldato and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Michael Dicay

26 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Dicay Canada 21 640 623 438 330 286 26 1.9k
Yiming Lin China 23 1.1k 1.8× 338 0.5× 533 1.2× 401 1.2× 106 0.4× 40 2.6k
Donna‐Marie McCafferty Canada 27 730 1.1× 130 0.2× 312 0.7× 417 1.3× 384 1.3× 39 2.2k
Michael J. Menconi United States 32 1.2k 1.9× 184 0.3× 691 1.6× 408 1.2× 120 0.4× 65 2.9k
M. L. Clark United Kingdom 31 467 0.7× 215 0.3× 1.1k 2.4× 454 1.4× 81 0.3× 70 2.7k
Gary R. Martin Canada 20 474 0.7× 444 0.7× 409 0.9× 444 1.3× 64 0.2× 35 1.8k
Luke J. Janssen Canada 32 1.1k 1.8× 266 0.4× 1.2k 2.7× 266 0.8× 206 0.7× 100 3.0k
H Sadowska-Krowicka United States 13 302 0.5× 219 0.4× 814 1.9× 166 0.5× 80 0.3× 22 1.5k
M. B. Grisham United States 24 545 0.9× 129 0.2× 575 1.3× 491 1.5× 96 0.3× 32 2.4k
Adrian Moore United Kingdom 29 1.6k 2.6× 226 0.4× 317 0.7× 251 0.8× 520 1.8× 78 3.2k
Hiroki Fujita Japan 30 1.2k 1.9× 74 0.1× 624 1.4× 543 1.6× 200 0.7× 103 3.7k

Countries citing papers authored by Michael Dicay

Since Specialization
Citations

This map shows the geographic impact of Michael Dicay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Dicay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Dicay more than expected).

Fields of papers citing papers by Michael Dicay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Dicay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Dicay. The network helps show where Michael Dicay may publish in the future.

Co-authorship network of co-authors of Michael Dicay

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Dicay. A scholar is included among the top collaborators of Michael Dicay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Dicay. Michael Dicay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dicay, Michael, Cristiane Hatsuko Baggio, Bernard Renaux, et al.. (2018). Interferon gamma decreases intestinal epithelial aquaporin 3 expression through downregulation of constitutive transcription. Journal of Molecular Medicine. 96(10). 1081–1093. 8 indexed citations
2.
Lopes, Fernando, Åsa V. Keita, José L. Reyes, et al.. (2018). ER-stress mobilization of death-associated protein kinase-1–dependent xenophagy counteracts mitochondria stress–induced epithelial barrier dysfunction. Journal of Biological Chemistry. 293(9). 3073–3087. 37 indexed citations
3.
Wallace, John L., David Vaughan, Michael Dicay, Wallace K. MacNaughton, & Gilberto De Nucci. (2017). Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic. Antioxidants and Redox Signaling. 28(16). 1533–1540. 98 indexed citations
4.
Spohn, Stephanie N., Francesca Bianco, Catherine M. Keenan, et al.. (2016). Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon. Gastroenterology. 151(5). 933–944.e3. 99 indexed citations
5.
MacEachern, Sarah J., Bhavik Anil Patel, Catherine M. Keenan, et al.. (2015). Inhibiting Inducible Nitric Oxide Synthase in Enteric Glia Restores Electrogenic Ion Transport in Mice With Colitis. Gastroenterology. 149(2). 445–455.e3. 55 indexed citations
6.
D’Mello, Charlotte, Natalie J. Ronaghan, Michael Dicay, et al.. (2015). Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain. Journal of Neuroscience. 35(30). 10821–10830. 146 indexed citations
7.
Dicay, Michael, et al.. (2015). Interferon-γ Suppresses Intestinal Epithelial Aquaporin-1 Expression via Janus Kinase and STAT3 Activation. PLoS ONE. 10(3). e0118713–e0118713. 13 indexed citations
8.
Wang, Arthur, Åsa V. Keita, Van Phan, et al.. (2014). Targeting Mitochondria-Derived Reactive Oxygen Species to Reduce Epithelial Barrier Dysfunction and Colitis. American Journal Of Pathology. 184(9). 2516–2527. 133 indexed citations
9.
Fichna, Jakub, Michael Dicay, Anna Janecka, et al.. (2011). Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors*. Inflammatory Bowel Diseases. 18(6). 1137–1145. 64 indexed citations
10.
Fichna, Jakub, Michael Dicay, Simon A. Hirota, et al.. (2011). Differential effects of salvinorin A on endotoxin-induced hypermotility and neurogenic ion transport in mouse ileum. Neurogastroenterology & Motility. 23(6). 583–e212. 12 indexed citations
11.
Wallace, John L., Linda Vong, Webb McKnight, Michael Dicay, & Gary R. Martin. (2009). Endogenous and Exogenous Hydrogen Sulfide Promotes Resolution of Colitis in Rats. Gastroenterology. 137(2). 569–578.e1. 260 indexed citations
12.
Martin, Gary R., G. Webb McKnight, Michael Dicay, et al.. (2009). Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract. Digestive and Liver Disease. 42(2). 103–109. 98 indexed citations
13.
Chávez‐Piña, Aracely Evangelina, W. McKnight, Michael Dicay, et al.. (2008). Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety. British Journal of Pharmacology. 155(6). 857–864. 19 indexed citations
14.
Chávez‐Piña, Aracely Evangelina, W. McKnight, Michael Dicay, Gilberto Castañeda‐Hernández, & John L. Wallace. (2007). Mechanisms underlying the anti‐inflammatory activity and gastric safety of acemetacin. British Journal of Pharmacology. 152(6). 930–938. 21 indexed citations
15.
Wallace, John L., Michael Dicay, Webb McKnight, & Gary R. Martin. (2007). Hydrogen sulfide enhances ulcer healing in rats. The FASEB Journal. 21(14). 4070–4076. 191 indexed citations
16.
Wallace, John L., et al.. (2006). Platelets accelerate gastric ulcer healing through presentation of vascular endothelial growth factor. British Journal of Pharmacology. 148(3). 274–278. 39 indexed citations
17.
Wallace, John L., Stella Regina Zamunér, Webb McKnight, et al.. (2004). Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 286(1). G76–G81. 45 indexed citations
18.
Fiorucci, Stefano, Octávio Menezes de Lima, Andrea Mencarelli, et al.. (2002). Cyclooxygenase-2–derived lipoxin A4 increases gastric resistance to aspirin-induced damage. Gastroenterology. 123(5). 1598–1606. 109 indexed citations
19.
Muscará, Marcelo N., Fina Lovren, Webb McKnight, et al.. (2001). Vasorelaxant effects of a nitric oxide‐releasing aspirin derivative in normotensive and hypertensive rats. British Journal of Pharmacology. 133(8). 1314–1322. 54 indexed citations
20.
Wallace, John L., Marcelo N. Muscará, Webb McKnight, et al.. (1999). In Vivo Antithrombotic Effects of a Nitric Oxide-Releasing Aspirin Derivative, NCX-4016. Thrombosis Research. 93(1). 43–50. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiming Lin Breakdown of academic impact, for papers by Donna‐Marie McCafferty Breakdown of academic impact, for papers by Michael J. Menconi Breakdown of academic impact, for papers by M. L. Clark Breakdown of academic impact, for papers by Gary R. Martin Breakdown of academic impact, for papers by Luke J. Janssen Breakdown of academic impact, for papers by H Sadowska-Krowicka Breakdown of academic impact, for papers by M. B. Grisham Breakdown of academic impact, for papers by Adrian Moore Breakdown of academic impact, for papers by Hiroki Fujita
Rankless by CCL
2026